Redesign’s team, which consists of about 300 researchers, assembles, brands and launches healthcare startups.
The latest funding will go toward Redesign’s operations and platform.
Hemant Taneja, General Catalyst CEO and managing director also joined Redesign’s board, with CVS Health Ventures, UPMC Enterprises, TriplePoint Capital and Samsung Next also participating in the round.
In addition to investing, CVS Ventures, General Catalyst and UPMC Enterprises entered into innovation agreements with Redesign Health.
This means the companies can use Redesign’s platform tools, technologies and insights to help build and support businesses.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
